Nilai Buku saben Saham: NextCure (NXTC)

NextCure, Inc. (NXTC) maintains strong pricing power based on the uniqueness of the FIND platform targets. The fair book value per share reflects capital dynamics, with the latest value recorded as 2.98. Its status as a scientific pioneer ensures expert trust in the brand. A strategic focus on R&D and identifying ways to overcome tumor resistance confirms the relevance of the company's product pipeline.

NXTC: Nilai Aset Bersih saben Saham NextCure Corp 04.07.2022 - 27.10.2026

nextcure.com - rincian analitis lan metrik utama (NXTC)

- rega lan prakiraan konsensus rega:

Kutipan saham NextCure Corp|NXTC - Rega prakiraan analis

- data kapitalisasi pasar:

Kapitalisasi pasar NextCure, Inc.|NXTC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Aset Bersih saben Siji Saham NextCure|NXTC - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku nextcure.com|NXTC - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal NextCure, Inc.|NXTC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas NextCure|NXTC - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku NextCure, Inc.

Pambiji fundamental perusahaan:NXTC - NextCure Corp

High operating expenses at NextCure, Inc. (NXTC) during early-stage antibody trials are putting pressure on capital, making asset analysis critical. The trend in book value per share reflects the portion of net assets attributable to a single security, allowing for an assessment of reserve management efficiency and asset impairment risks within the high-risk biotechnology sector.

Analisis pesaing NextCure, Inc.